DK0717635T3 - Fremgangsmåder til reduktion af gastrointestinal motilitet - Google Patents
Fremgangsmåder til reduktion af gastrointestinal motilitetInfo
- Publication number
- DK0717635T3 DK0717635T3 DK94927398T DK94927398T DK0717635T3 DK 0717635 T3 DK0717635 T3 DK 0717635T3 DK 94927398 T DK94927398 T DK 94927398T DK 94927398 T DK94927398 T DK 94927398T DK 0717635 T3 DK0717635 T3 DK 0717635T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- gastrointestinal motility
- reducing gastrointestinal
- gastric emptying
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11838193A | 1993-09-07 | 1993-09-07 | |
PCT/US1994/010225 WO1995007098A1 (fr) | 1993-09-07 | 1994-09-07 | Procedes de regulation de la motilite gastro-intestinale |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0717635T3 true DK0717635T3 (da) | 2000-12-11 |
Family
ID=22378228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94927398T DK0717635T3 (da) | 1993-09-07 | 1994-09-07 | Fremgangsmåder til reduktion af gastrointestinal motilitet |
Country Status (23)
Country | Link |
---|---|
US (4) | US6114304A (fr) |
EP (1) | EP0717635B1 (fr) |
JP (2) | JP3821839B2 (fr) |
KR (2) | KR100429966B1 (fr) |
CN (1) | CN1134110A (fr) |
AT (1) | ATE197549T1 (fr) |
AU (1) | AU7685894A (fr) |
BG (1) | BG100463A (fr) |
BR (1) | BR9407424A (fr) |
CA (1) | CA2171207C (fr) |
CZ (1) | CZ69596A3 (fr) |
DE (1) | DE69426304T2 (fr) |
DK (1) | DK0717635T3 (fr) |
ES (1) | ES2154299T3 (fr) |
GR (1) | GR3035387T3 (fr) |
HU (1) | HUT73490A (fr) |
NO (1) | NO960899L (fr) |
PT (1) | PT717635E (fr) |
RU (1) | RU2177331C2 (fr) |
SG (1) | SG98356A1 (fr) |
SK (1) | SK31496A3 (fr) |
WO (1) | WO1995007098A1 (fr) |
ZA (1) | ZA946881B (fr) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
US6114304A (en) * | 1993-09-07 | 2000-09-05 | Amylin Pharmaceuticals, Inc. | Methods for regulating gastrointestinal motility |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
DE69739172D1 (de) * | 1996-08-08 | 2009-01-29 | Amylin Pharmaceuticals Inc | Regulation gastrointestinaler beweglichkeit |
ES2247676T3 (es) | 1997-01-07 | 2006-03-01 | Amylin Pharmaceuticals, Inc. | Uso de las exendinas y de los agonistas de las mismas para la reduccion de la ingesta alimenticia. |
US7101853B2 (en) | 1997-05-06 | 2006-09-05 | Amylin Pharmaceuticals, Inc. | Method for treating or preventing gastritis using amylin or amylin agonists |
US7910548B2 (en) * | 1997-06-06 | 2011-03-22 | Amylin Pharmaceuticals, Inc. | Methods for treating obesity |
US6936584B1 (en) | 1998-02-13 | 2005-08-30 | Amylin Pharmaceuticals, Inc. | Mixed amylin activity compounds |
WO1999040928A1 (fr) | 1998-02-13 | 1999-08-19 | Amylin Pharmaceuticals, Inc. | Nouveaux composes a activite mixte par rapport a l'amyline |
US7399489B2 (en) | 1999-01-14 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Exendin analog formulations |
US6872700B1 (en) | 1999-01-14 | 2005-03-29 | Amylin Pharmaceuticals, Inc. | Methods for glucagon suppression |
NZ512663A (en) | 1999-01-14 | 2004-05-28 | Amylin Pharmaceuticals Inc | Novel exendin agonist formulations and methods of administration thereof |
US6924264B1 (en) | 1999-04-30 | 2005-08-02 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists |
US6528486B1 (en) | 1999-07-12 | 2003-03-04 | Zealand Pharma A/S | Peptide agonists of GLP-1 activity |
US6451806B2 (en) | 1999-09-29 | 2002-09-17 | Adolor Corporation | Methods and compositions involving opioids and antagonists thereof |
US6469030B2 (en) | 1999-11-29 | 2002-10-22 | Adolor Corporation | Methods for the treatment and prevention of ileus |
ES2440190T3 (es) | 2000-03-03 | 2014-01-28 | C. R. Bard, Inc. | Dispositivo endoscópico de aposición de tejido con múltiples puertos de succión |
US7220266B2 (en) | 2000-05-19 | 2007-05-22 | C. R. Bard, Inc. | Tissue capturing and suturing device and method |
US6451813B1 (en) | 2001-01-26 | 2002-09-17 | R. T. Alamo Ventures I, Llc | Treatment of gastroparesis in certain patient groups |
JP2006510593A (ja) * | 2002-09-12 | 2006-03-30 | ザ ユニヴァーシティ オヴ シカゴ | 胃内容排出及び胃不全麻痺のモニタリング及び診断 |
WO2004037168A2 (fr) * | 2002-10-18 | 2004-05-06 | Amylin Pharmaceuticals, Inc. | Traitement de la pancreatite avec de l'amyline |
US7655618B2 (en) | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
WO2004060387A1 (fr) * | 2002-12-27 | 2004-07-22 | Diobex, Inc. | Compositions et procedes de prevention et reduction de l'hypoglycemie induite par l'insuline |
US20070275877A1 (en) * | 2003-08-29 | 2007-11-29 | Amylin Pharmaceuticals, Inc. | Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders |
WO2006083254A1 (fr) | 2004-02-11 | 2006-08-10 | Amylin Pharmaceuticals, Inc. | Peptides de la famille amyline et procedes de production et d'utilisation desdits peptides |
US7399744B2 (en) * | 2004-03-04 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Methods for affecting body composition |
US7878978B2 (en) | 2004-03-18 | 2011-02-01 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Use of relaxin to increase arterial compliance |
US8172857B2 (en) | 2004-08-27 | 2012-05-08 | Davol, Inc. | Endoscopic tissue apposition device and method of use |
US8394765B2 (en) * | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
BRPI0518241A (pt) | 2004-11-01 | 2008-04-22 | Amylin Pharmaceuticals Inc | métodos para tratar obesidade e doenças e distúrbios relacionados à obesidade |
EP1871403B1 (fr) | 2005-03-31 | 2010-09-08 | Amylin Pharmaceuticals, Inc. | Compositions et procedes pour le controle, la prevention et le traitement des troubles de l'alimentation |
WO2007104786A1 (fr) | 2006-03-15 | 2007-09-20 | Novo Nordisk A/S | Melanges d'amyline et d'insuline |
MX2008012221A (es) * | 2006-03-23 | 2009-03-06 | Amylin Pharmaceuticals Inc | Endotelina y agonistas del receptor de endotelina en el tratamiento de enfermedades metabolicas. |
US20090181890A1 (en) * | 2006-03-31 | 2009-07-16 | Amylin Pharmaceuticals , Inc. | Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
US8309522B2 (en) | 2007-02-05 | 2012-11-13 | Amylin Pharmaceuticals, Llc | Neuromedin and FN-38 peptides for treating psychiatric diseases |
CN101939022A (zh) * | 2007-11-14 | 2011-01-05 | 安米林药品公司 | 治疗肥胖以及肥胖相关疾病和病症的方法 |
MX2011009559A (es) | 2009-03-12 | 2012-01-12 | Nordic Bioscience As | Tratamiento de la diabetes y el sindrome metabolico. |
US8748375B2 (en) * | 2009-03-17 | 2014-06-10 | Amylin Pharmaceuticals, Llc | Methods for affecting body composition using amylin agonists |
CA2797133C (fr) | 2010-04-27 | 2019-08-06 | Zealand Pharma A/S | Conjugues peptidiques d'antagonistes du recepteur de glp-1 et de gastrine, et leur utilisation |
MX2014005351A (es) | 2011-11-03 | 2014-05-28 | Zealand Pharma As | Conjugados de gastrina peptidicos de agonistas de receptor glp-1. |
MX356957B (es) | 2012-07-23 | 2018-06-20 | Zealand Pharma As | Analogos del glucagon. |
TWI608013B (zh) | 2012-09-17 | 2017-12-11 | 西蘭製藥公司 | 升糖素類似物 |
US9988429B2 (en) | 2013-10-17 | 2018-06-05 | Zealand Pharma A/S | Glucagon analogues |
MX368436B (es) | 2013-10-17 | 2019-10-03 | Zealand Pharma As | Analogos de glucagon acilados. |
WO2015067716A1 (fr) | 2013-11-06 | 2015-05-14 | Zealand Pharma A/S | Composés agonistes triples glucagon-glp-1-gip |
EP3065767B1 (fr) | 2013-11-06 | 2020-12-30 | Zealand Pharma A/S | Composés agonistes doubles gip-glp-1 et procédés |
WO2015196174A1 (fr) | 2014-06-20 | 2015-12-23 | Greene Howard E | Dispositifs et procédés d'administration de perfusion |
AU2015340586B2 (en) | 2014-10-29 | 2020-04-30 | Zealand Pharma A/S | GIP agonist compounds and methods |
PE20180497A1 (es) | 2015-03-18 | 2018-03-09 | Zealand Pharma As | Analogos de amilina |
BR112017022009A2 (pt) | 2015-04-16 | 2018-07-03 | Zealand Pharma A/S | ?composto, método de produção e síntese do mesmo e seu uso, composição e conjunto terapêutico? |
TWI784968B (zh) | 2016-09-09 | 2022-12-01 | 丹麥商西蘭製藥公司 | 澱粉素類似物 |
BR112019010624A2 (pt) | 2016-12-09 | 2019-10-22 | Zealand Pharma As | agonistas duplos de glp-1/glp-2 acilados e composição |
WO2018122278A1 (fr) | 2016-12-27 | 2018-07-05 | Adocia | Compositions sous forme de solution aqueuse injectable comprenant de l'amyline, un agoniste au récepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
MA49678A (fr) | 2017-07-27 | 2021-04-14 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant au moins l'insuline humaine a21g et un suppresseur de glucagon a action prandiale |
FR3083085B1 (fr) | 2018-06-29 | 2020-10-02 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
MX2020005916A (es) | 2017-12-07 | 2020-10-19 | Adocia | Composiciones en forma de una solución acuosa inyectable que comprende amilina, un receptor agonista de amilina o un análogo de amilina y un copoliaminoácido. |
US11129877B2 (en) | 2017-12-07 | 2021-09-28 | Adocia | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid |
EP3740195A1 (fr) | 2017-12-07 | 2020-11-25 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
US20190275108A1 (en) | 2017-12-07 | 2019-09-12 | Adocia | Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analogue and a co-polyamino acid |
FR3083086A1 (fr) | 2018-06-29 | 2020-01-03 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
FR3084586B1 (fr) | 2018-08-03 | 2020-11-06 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4451394A (en) * | 1982-10-25 | 1984-05-29 | American Home Products Corporation | Dodecapeptides preventing glucose and triglyceride assimilation |
US4530838A (en) * | 1983-07-08 | 1985-07-23 | The Salk Institute For Biological Studies | Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals |
US4690486A (en) * | 1985-04-29 | 1987-09-01 | Texas Instruments Incorporated | Four position interlacing apparatus |
GB8720115D0 (en) * | 1987-08-26 | 1987-09-30 | Cooper G J S | Treatment of diabetes mellitus |
US5367052A (en) * | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
GB8709871D0 (en) * | 1987-04-27 | 1987-06-03 | Turner R C | Peptides |
US5266561A (en) * | 1988-01-11 | 1993-11-30 | Amylin Pharmaceuticals, Inc. | Treatment of type 2 diabetes mellitus |
US5175145A (en) * | 1988-08-26 | 1992-12-29 | Amylin Pharmaceuticals, Inc. | Treatment of diabetes mellitus with amylin agonists |
US5166192A (en) * | 1989-05-09 | 1992-11-24 | Mathias John R | Treatment of motility disorders with a GnRH analog |
US5260275A (en) * | 1990-08-14 | 1993-11-09 | Amylin Pharmaceuticals, Inc. | Hypoglycemics |
US5187154A (en) * | 1990-12-13 | 1993-02-16 | Board Of Regents, The University Of Texas System | Diagnosis and treatment of humans with diabetes or at risk to develop diabetes |
US5264372A (en) * | 1991-03-15 | 1993-11-23 | Amylin Pharmaceuticals, Inc. | Receptor-based screening methods for amylin agonists and antagonists |
US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
HU222249B1 (hu) * | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
DK0586589T3 (da) * | 1991-05-24 | 1997-09-22 | Amylin Pharmaceuticals Inc | Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande |
US5580953A (en) * | 1991-08-14 | 1996-12-03 | Amylin Pharmaceuticals, Inc. | Amylin antagonist peptides and uses therefor |
CA2100745C (fr) * | 1991-11-19 | 2007-07-31 | Laura S. L. Gaeta | Peptides agonistes de l'amyline et leur utilisation |
US5376638A (en) * | 1992-09-01 | 1994-12-27 | Amylin Pharmaceuticals, Inc. | Methods for treating renin-related disorders with amylin antagonists |
WO1994020116A1 (fr) * | 1993-03-10 | 1994-09-15 | University Of Alabama Research Foundation | Amorces artificielles pour la synthese du glycogene |
US6114304A (en) * | 1993-09-07 | 2000-09-05 | Amylin Pharmaceuticals, Inc. | Methods for regulating gastrointestinal motility |
US6143718A (en) * | 1995-06-07 | 2000-11-07 | Amylin Pharmaceuticals, Inc. | Treatment of Type II diabetes mellutis with amylin agonists |
-
1994
- 1994-09-07 US US08/302,069 patent/US6114304A/en not_active Expired - Lifetime
- 1994-09-07 KR KR10-2003-7005868A patent/KR100429966B1/ko not_active IP Right Cessation
- 1994-09-07 AU AU76858/94A patent/AU7685894A/en not_active Abandoned
- 1994-09-07 DK DK94927398T patent/DK0717635T3/da active
- 1994-09-07 DE DE69426304T patent/DE69426304T2/de not_active Expired - Lifetime
- 1994-09-07 JP JP50882395A patent/JP3821839B2/ja not_active Expired - Lifetime
- 1994-09-07 CA CA2171207A patent/CA2171207C/fr not_active Expired - Lifetime
- 1994-09-07 SG SG9607979A patent/SG98356A1/en unknown
- 1994-09-07 HU HU9600558A patent/HUT73490A/hu unknown
- 1994-09-07 RU RU96107891/14A patent/RU2177331C2/ru active
- 1994-09-07 KR KR1019960701160A patent/KR100391399B1/ko not_active IP Right Cessation
- 1994-09-07 CN CN94193931A patent/CN1134110A/zh active Pending
- 1994-09-07 EP EP94927398A patent/EP0717635B1/fr not_active Expired - Lifetime
- 1994-09-07 BR BR9407424A patent/BR9407424A/pt not_active Application Discontinuation
- 1994-09-07 SK SK314-96A patent/SK31496A3/sk unknown
- 1994-09-07 ZA ZA946881A patent/ZA946881B/xx unknown
- 1994-09-07 AT AT94927398T patent/ATE197549T1/de active
- 1994-09-07 ES ES94927398T patent/ES2154299T3/es not_active Expired - Lifetime
- 1994-09-07 CZ CZ96695A patent/CZ69596A3/cs unknown
- 1994-09-07 WO PCT/US1994/010225 patent/WO1995007098A1/fr active IP Right Grant
- 1994-09-07 PT PT94927398T patent/PT717635E/pt unknown
-
1995
- 1995-06-05 US US08/471,675 patent/US5795861A/en not_active Expired - Lifetime
-
1996
- 1996-03-06 NO NO960899A patent/NO960899L/no unknown
- 1996-03-29 BG BG100463A patent/BG100463A/xx unknown
-
2000
- 2000-05-22 US US09/576,062 patent/US6608029B1/en not_active Expired - Fee Related
-
2001
- 2001-02-07 GR GR20010400214T patent/GR3035387T3/el unknown
-
2003
- 2003-08-18 US US10/643,681 patent/US7407934B2/en not_active Expired - Fee Related
-
2004
- 2004-08-11 JP JP2004234571A patent/JP2004331674A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0717635T3 (da) | Fremgangsmåder til reduktion af gastrointestinal motilitet | |
CA2262647A1 (fr) | Methodes de regulation de la motilite gastro-intestinale | |
CY1107752T1 (el) | Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης | |
NZ504258A (en) | Exendin 3 and 4 agonist compounds for the treatment of diabetes | |
HK1042496A1 (en) | Novel heteroaromatic inhibitors of fructose 1,6-bishosphatase | |
BR9814189A (pt) | "compostos agonistas da exendina" | |
ATE234092T1 (de) | 2-alkylpyrrolidine | |
TR200100079T2 (tr) | Glikoza karşı ß-hücre tepkisini arttıran glukagon benzeri peptid-1 | |
CA2274596A1 (fr) | Compositions et procedes servant a ameliorer le fonctionnement gastro-intestinal | |
PL328858A1 (en) | Immunogenous peptides | |
HK1064950A1 (en) | Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) | |
ATE543451T1 (de) | Bioabsorbierbare, osteogenetische knochenplatte | |
UA50761C2 (uk) | Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
NO894008D0 (no) | Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme. | |
WO1999064065A3 (fr) | Therapie anti-tumorale et imagerie des tumeurs | |
PT979098E (pt) | Metodo para o tratamento da hiperprolactinemia e de prolactinomas | |
ATE204169T1 (de) | Polyamin-antagonisten enthaltende intraokulare irrigationslösung | |
RU2002112556A (ru) | Способ лечения мужского бесплодия | |
UA29280A (uk) | Спосіб лікування флегмони шлунку | |
GB9709815D0 (en) | Therapeutic method | |
UA23123A (uk) | Спосіб хірургічhого лікуваhhя hавколососочкових виразок дваhадцятипалої кишки | |
UA32280A (uk) | Спосіб формування тонко-товстокишкового анастомозу бік у бік | |
UA33424A (uk) | Пристрій для профілактики та лікування постмастектомічного синдрому | |
CL2004001066A1 (es) | Procedimiento de preparacion de mesilato de nelfinavir, inhibidor de vih-proteasa, util en el tratamiento del sida, compuestos intermediarios; y procedimientos de preparacion de dichos intermediarios (div. sol. 1804-97). |